SCHEMBL1487797

SCHEMBL1487797

C#Cc1c([SiH](C(C)C)C(C)C)ccc2cc3cc4cc5ccccc5cc4cc3cc12

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HIF1A Q16665 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP1A1 P04798 1/20 0.31
UGT2B7 P16662 1/20 0.30
ERBB2 P04626 1/20 0.30
CYP1A2 P05177 1/20 0.30
FYN P06241 1/20 0.30
MAOA P21397 1/20 0.30
ACHE P22303 1/20 0.30
AHR P35869 1/20 0.30
CYP3A4 P08684 1/20 0.30
ALOX15 P16050 1/20 0.30
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
HBB P68871 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1487793 0.77 CYP1B1 (0.32) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A1
SCHEMBL1487794 0.75 CYP1A1 (0.31) CYP1B1CYP1A1UGT2B7
SCHEMBL3723965 0.75 NQO1 (0.32) CYP1B1CYP1A1UGT2B7
SCHEMBL27770259 0.73 ALDH1A1 (0.32) CYP1B1ALDH1A1HIF1AHSD17B10UGT2B7
SCHEMBL27780597 0.71 ALDH1A1 (0.38) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A1
SCHEMBL7944103 0.71 ALDH1A1 (0.40) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A1
SCHEMBL27860879 0.69 ALDH1A1 (0.39) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A1
SCHEMBL28390957 0.69 ALDH1A1 (0.35) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A1
SCHEMBL27991889 0.68 CYP1A2 (0.32) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A2
SCHEMBL2834902 0.67 ALDH1A1 (0.40) CYP1B1ALDH1A1HIF1AHSD17B10CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102124015-B Silylethynyl pentacene compounds and compositions, and methods of making and using the same 3M INNOVATIVE PROPERTIES CO 2015-03-11 CN disclosed
EP-2307427-B1 SILYLETHYNYL PENTACENE COMPOUNDS AND COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES CO (US) 2015-02-18 EP disclosed
US-8956555-B2 Silylethynyl pentacene compounds and compositions and methods of making and using the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-02-17 US disclosed
EP-2307427-A1 SILYLETHYNYL PENTACENE COMPOUNDS AND COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME 3M Innovative Properties Company (US) 2011-04-13 EP disclosed
US-20110073813-A1 Silylethynyl Pentacene Compounds and Compositions and Methods of Making and Using the Same 3M INNOVATIVE PROPERTIES COMPANY 2011-03-31 US disclosed
WO-2009155106-A1 SILYLETHYNYL PENTACENE COMPOUNDS AND COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110073813-A1 Silylethynyl Pentacene Compounds and Compositions and Methods of Making and Using the Same SRM, GMNN, SRI CYP1B1 1281/4885ALDH1A1 2100/4885HIF1A 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.